We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$141M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$127M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$109M
4
MRK icon
Merck
MRK
+$97.7M
5
ZBH icon
Zimmer Biomet
ZBH
+$80.8M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BG icon
226
Bunge Global
BG
$21.5B
$14.7M 0.09%
322,458
+171,586
+114% +$7.67M
ELAN icon
227
Elanco Animal Health
ELAN
$11.2B
$14.5M 0.09%
+520,409
New +$13.2M
COHR
228
DELISTED
Coherent Inc
COHR
$14.5M 0.09%
+130,718
New +$15.8M
GBT
229
DELISTED
Global Blood Therapeutics, Inc.
GBT
$14.3M 0.09%
259,168
-276,108
-52% -$17.5M
SITE icon
230
SiteOne Landscape Supply
SITE
$4.38B
$14.1M 0.09%
+115,809
New +$13.9M
ABT icon
231
Abbott
ABT
$188B
$14.1M 0.09%
129,297
-344,973
-73% -$35M
VALE icon
232
Vale
VALE
$63.3B
$14M 0.09%
1,323,780
+1,188,152
+876% +$13.3M
MRCY icon
233
Mercury Systems
MRCY
$6.53B
$13.8M 0.09%
+178,116
New +$13.5M
COLD icon
234
Americold
COLD
$4.17B
$13.5M 0.09%
+376,272
New +$14.2M
APH icon
235
Amphenol
APH
$209B
$13.4M 0.09%
495,424
+439,416
+785% +$11.6M
PRI icon
236
Primerica
PRI
$9.69B
$13.4M 0.09%
118,275
+113,484
+2,369% +$13.8M
GRFS
237
Grifois
GRFS
$5.5B
$13.4M 0.09%
770,492
+615,086
+396% +$10.9M
SPWH icon
238
Sportsman's Warehouse
SPWH
$47.2M
$13.3M 0.09%
927,943
+431,621
+87% +$6.64M
TAK icon
239
Takeda Pharmaceutical
TAK
$56B
$13.1M 0.08%
734,010
+264,213
+56% +$4.81M
GSK icon
240
GSK
GSK
$104B
$13.1M 0.08%
+278,043
New +$13.9M
MAR icon
241
Marriott International
MAR
$90.4B
$12.9M 0.08%
139,838
+92,969
+198% +$8.77M
ENB icon
242
Enbridge
ENB
$112B
$12.9M 0.08%
443,540
+122,307
+38% +$3.85M
VAR
243
DELISTED
Varian Medical Systems, Inc.
VAR
$12.9M 0.08%
74,895
+18,687
+33% +$2.94M
VZ icon
244
Verizon
VZ
$195B
$12.9M 0.08%
+216,410
New +$12.6M
ILMN icon
245
Illumina
ILMN
$28.9B
$12.8M 0.08%
+42,459
New +$14.6M
Z icon
246
Zillow
Z
$7.55B
$12.6M 0.08%
123,899
-18,504
-13% -$1.45M
MMP
247
DELISTED
Magellan Midstream Partners, L.P.
MMP
$12.6M 0.08%
367,345
+44,171
+14% +$1.75M
CMCSA icon
248
Comcast
CMCSA
$88.9B
$12.5M 0.08%
270,720
+108,125
+66% +$4.7M
ECL icon
249
Ecolab
ECL
$79.7B
$12.4M 0.08%
62,229
-113,522
-65% -$22.7M
ITCI
250
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$12.3M 0.08%
+480,301
New +$11M
8 9
10
11 12

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.